ISSX Overview 4
ISSX Corporate Supporters 5
Upcoming ISSX Meetings 6
Abstracts of Plenary and Symposia Presentations (Monday, October 19, 2009)
Plenary Session: Disposition and Dynamics of Biologics: Where Are We Headed?
Abstract: 1–4 7
Symposium 1: Biochemistry of Drug Metabolizing Enzymes
Abstracts: 5–8 7–9
Symposium 2: New Analytical Technologies for the Next Generation of Biological Discovery
Abstracts: 9–12 10–11
Abstracts of Symposia Presentations (Tuesday, October 20, 2009)
Symposium 3: Nuclear Receptor Regulation of Bile Acid and Drug Metabolism
Abstract: 13–16 11–12
Symposium 4: Recent Advances and New Technologies
Abstracts: 17–20 12
Symposium 5: Mechanisms of Toxicity
Abstracts: 21–24 13–14
Symposium 6: Overcoming the Challenges of Delivery of Drugs across the Blood-Brain Barrier
Abstracts: 25–28 15–16
Abstracts of Symposia Presentations (Wednesday, October 21, 2009)
Symposium 7: Scientific and Regulatory Perspectives on Non-CYP Drug Metabolizing Enzymes and Transporters
Abstracts: 29–32 16–18
Symposium 8: Regulation of Xenobiotic Enzymes and Transporters
Abstracts: 33–36 18–19
Symposium 9: Enhancing Experimental Drug Discovery with Computation
Abstracts: 37–40 19–21
Symposium 10: Pharmacogenetics of Adverse Drug Reactions
Abstracts: 41–44 22
Abstracts of Symposia Presentations (Thursday, October 22, 2009)
Symposium 11: Clinical Drugs, Environmental Chemicals, and Health
Abstracts: 45–48 22–24
Symposium 12: Prediction of Drug-Drug Interactions
Abstracts: 49–52 24–25
Finalists for the Predoctoral (Graduate) Poster Awards Competition (Monday, October 19–Wednesday, October 21)
Abstracts: 53–58 26–29
Finalists for the Postdoctoral Poster Awards Competition (Monday, October 19–Wednesday, October 21)
Abstracts: 59–65 29–32
Abstracts of Poster Presentations (Monday, October 19, 2009)
Analytical
Abstracts: 66–73 33–36
Bioavailability
Abstracts: 74 37
Clearance Prediction
Abstracts: 75–77 37–38
Conjugation Reactions and Enzymes
Abstracts: 78–85 39–42
Cytochrome P450
Abstracts: 86–118 43–57
Differences in Metabolism (species, gender, age, diseases)
Abstracts: 119–129 58–63
Disposition
Abstracts: 130–137 63–67
Drug Discovery and Development
Abstracts: 138–144 67–71
Drug Interaction
Abstracts: 145–170 71–83
Abstracts of Poster Presentations (Tuesday, October 20, 2009)
Enzyme Induction
Abstract: 171–183 84–90
Enzyme Inhibition/Inactivation
Abstracts: 184–200 90–98
Extrahepatic Metabolism
Abstracts: 201–203 99
Gene Expression and Regulation
Abstracts: 204–218, 374 100–107, 186
Genomics/Metabonomics/Proteomics
Abstracts: 219–221 108
Hepatocytes
Abstracts: 222–231 109–113
High Throughput Techniques
Abstracts: 232–238 114–117
In Silico
Abstracts: 239–245 117–120
In Vitro Techniques
Abstract: 246–251 121–123
Mechanisms of Xenobiotic Toxicities
Abstracts: 252–264 123–129
Metabolic Profiling
Abstracts: 265–271 130–133
Abstracts of Poster Presentations (Wednesday, October 21, 2009)
Metabolic Profiling
Abstracts: 272–278 134–137
Metabolism
Abstracts: 279–305 137–151
Non-P450 Phase I Enzymes
Abstracts: 306–311 151–153
Pharmacogenetics
Abstracts: 312–323 154–160
Pharmacokinetics and Pharmacodynamics
Abstracts: 324–338 161–168
Receptors/Nuclear Receptors
Abstract: 339–346 168–172
Transporters
Abstracts: 347–373 172–185
Author Index 187
Term Index 197